Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker (SYK) Surpasses Q3 Earnings and Revenue Estimates
06:20pm, Tuesday, 29'th Oct 2024
Stryker (SYK) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.78 per share. This compares to earnings of $2.46 per share a year ago.
Strong Segmental Performance to Drive Stryker's Q3 Earnings
03:11pm, Friday, 25'th Oct 2024
SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Insights Into Stryker (SYK) Q3: Wall Street Projections for Key Metrics
10:21am, Thursday, 24'th Oct 2024
Evaluate the expected performance of Stryker (SYK) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
PBH or SYK: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 23'rd Oct 2024
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two companies is the best option for those
Stryker: A High Quality MedTech Name Investors Should Own
10:42am, Thursday, 17'th Oct 2024
Stryker Corporation is a global leader in medical devices, with strong growth prospects driven by an aging population and technological advancements. SYK has a robust track record of double-digit earn
Stryker: More Earnings Growth And Higher Prices Ahead
07:45am, Thursday, 17'th Oct 2024
Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial resul
Stryker's Acquisition Spree: Double-Digit Growth on the Horizon
03:25pm, Friday, 11'th Oct 2024
Stryker SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boost its
Stryker's Acquisition Spree: Double-Digit Growth on the Horizon
09:33am, Thursday, 10'th Oct 2024
Stryker NYSE: SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boos
PBH vs. SYK: Which Stock Is the Better Value Option?
12:46pm, Monday, 07'th Oct 2024
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for
Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?
08:05am, Thursday, 03'rd Oct 2024
Styker's flagship, Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.
SYK Stock May Gain From Completion of Vertos Medical Acquisition
12:31pm, Wednesday, 02'nd Oct 2024
Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.
Stryker to announce its third quarter 2024 financial results
04:00pm, Tuesday, 01'st Oct 2024
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024. A press release will be i
Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
08:00am, Tuesday, 01'st Oct 2024
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management soluti
Reasons to Retain Stryker Stock in Your Portfolio for Now
10:17am, Thursday, 26'th Sep 2024
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Stryker Shares May Gain on the Completion of the Acquisition of NICO
11:35am, Monday, 23'rd Sep 2024
SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.
